Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Novo Nordisk Inc

NJ, United States

CMS manufacturer 100000000144

Open in the dashboard

General payments

$187,504,537

3,138,157 payments

Research payments

$75,450,326

4,101 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Novo Nordisk Inc reported paying $187,504,537 in general payments and $75,450,326 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $36,753,823 512,725
2025 Research $2,665,905 56
2024 General $25,466,536 495,369
2024 Research $5,414,170 1,778
2023 General $22,019,837 485,855
2023 Research $13,022,267 1,501
2022 General $33,939,339 522,321
2022 Research $4,660,798 203
2021 General $27,303,475 473,327
2021 Research $7,371,154 110
2020 General $15,227,775 261,554
2020 Research $22,470,979 239
2019 General $26,793,752 387,006
2019 Research $19,845,053 214

Breakdown

Top recipients General payments · program year 2025
  1. Montefiore Medical Center Teaching hospital · NY $323,375 1 payment
  2. Sonal Kumar Gastroenterology · New York, NY $111,103 46 payments
  3. Naim Alkhouri Gastroenterology · Westlake, OH $99,161 43 payments
  4. Aaron King Family Medicine · San Antonio, TX $97,158 81 payments
  5. Shveta Gupta Pediatric Hematology-Oncology · Orlando, FL $92,529 51 payments
  6. Matthew Budoff Cardiovascular Disease · Torrance, CA $87,918 43 payments
  7. Carolina Solis-Herrera Endocrinology, Diabetes & Metabolism · San Antonio, TX $87,859 74 payments
  8. University Hospital Teaching hospital · KY $86,400 4 payments
  9. Jennifer Domm Pediatric Hematology-Oncology · Nashville, TN $85,081 69 payments
  10. Marlon Ramilo Cardiovascular Disease · Modesto, CA $83,898 54 payments
Top research recipients Research payments · program year 2025
  1. University Of Washington School Of Medicine $733,618 10 payments
  2. Palo Alto Veterans Institute For Research $311,448 5 payments
  3. University Of Washington Med Ctr Teaching hospital · WA $191,822 3 payments
  4. Loma Linda University Medical Center Diabetes Treatment Center $188,254 1 payment
  5. Baylor College Of Medicine $180,000 2 payments
  6. Hospital Of The Univ Of Penna Teaching hospital · PA $163,982 1 payment
  7. University Of Texas Southwestern Medical Center $118,227 2 payments
  8. Regents Of The University Of Colorado, A Body Corporate, For And On Behalf Of The University Of Colo $113,070 1 payment
  9. Yale University Ct $101,291 3 payments
  10. Mayo Clinic $97,913 1 payment
Products the payments named General payments · program year 2025
  1. Ozempic Diabetes $16,397,902 50% · 77,964 recipients
  2. Wegovy Obesity $12,130,156 37% · 75,385 recipients
  3. Rybelsus Diabetes $3,021,064 9% · 55,524 recipients
  4. Sogroya Growth Hormone $469,498 1% · 624 recipients
  5. Alhemo Hemophilia $342,211 1% · 276 recipients

The top 5 of 16 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $7,906,115 22% · 3,359 practitioners
  2. Internal Medicine $4,097,786 11% · 16,896 practitioners
  3. Family Medicine $3,987,922 11% · 24,880 practitioners
  4. Cardiovascular Disease Internal Medicine $3,470,793 10% · 4,139 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $3,052,605 9% · 27,068 practitioners

The top 5 of 266 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $3,735,936 10% · 11,745 recipients
  2. California $3,439,388 9% · 10,308 recipients
  3. New York $3,403,269 9% · 7,648 recipients
  4. Florida $2,750,917 7% · 10,520 recipients
  5. North Carolina $1,927,331 5% · 5,672 recipients

The top 5 of 56 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $90,697,242 40,020 payments
  2. Food and Beverage $59,245,184 3,042,693 payments
  3. Consulting Fee $23,260,001 7,436 payments
  4. Travel and Lodging $11,754,960 32,045 payments
  5. Grant $1,343,183 199 payments
  6. Space rental or facility fees (teaching hospital only) $624,770 395 payments
  7. Education $488,598 15,318 payments
  8. Honoraria $80,650 49 payments
  9. Charitable Contribution $7,500 1 payment
  10. Compensation for serving as faculty or as a speaker for a medical education program $2,450 1 payment
Companies with a similar name General payments · program years 2019–2025
  1. Novo Nordisk AS Denmark $74,522,443
  2. Novo Nordisk Health Care AG Switzerland $2,056,435
  3. Novo Nordisk Research Center Seattle, Inc. MA, United States $30,771

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

3,138,157 general · 4,101 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record